Dupilumab in Eosinophilic Gastritis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients
- Status
- COMPLETED
- Phase
- PHASE4
Safety, Tolerability, and Pharmacokinetics of REGN5069 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied
- Status
- COMPLETED
- Phase
- PHASE3
Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
- Status
- COMPLETED
- Phase
- PHASE3
Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica
- Status
- TERMINATED
- Phase
- PHASE3
Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA
- Status
- TERMINATED
- Phase
- PHASE3
Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE1
R3470-3471-3479 (REGN-EB3) Expanded Access Protocol (EAP) for Treatment of Ebola Virus Disease
- Status
- AVAILABLE
- Phase
- N/A
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)
- Status
- COMPLETED
- Phase
- PHASE3
Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE2
The Impact of Pediatric Skin Disorders: The "Big" Study
- Status
- COMPLETED
- Phase
- N/A
The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial
- Status
- TERMINATED
- Phase
- PHASE4
Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Examine the Safety, Tolerability and Biological Effects of REGN4461 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3